Name: 글로벌 시장 동향
SKU: PH7243
Availability: InStock

보고서 요약(국문)

개요
전 세계 치은염 치료 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
치은염은 치은 조직의 염증성 질환으로, 가장 흔한 원인은 세균 감염입니다. 치주염과는 달리, 치은 부착 손실이 없으므로 접합상피의 이동도 없습니다. 이 질환은 치은 상피와 결합 조직의 연조직 부위에 국한됩니다. 모든 치주 질환 중 치은염은 가장 흔한 질환으로 여겨집니다.
치은염은 치은열구 또는 그 주변에 위치한 미생물 플라크 침착으로 인해 발생합니다. 치은염의 원인균으로 가장 밀접하게 관련된 미생물에는 Streptococcus, Fusobacterium, Actinomyces, Veillonella 및 Treponema 종이 있습니다. 박테로이데스(Bacteroides), 카프노사이토파가(Capnocytophaga), 그리고 아이케넬라(Eikenella) 또한 이 질병의 원인과 관련될 가능성이 있습니다.
시장 동향: 동인 및 제약 요인
인식 제고 및 관리 개선
또한, 가처분 소득 증가와 구강 건강의 중요성에 대한 인식 제고는 치은염 치료에 사용되는 제품을 포함한 고품질 구강 관리 제품에 대한 수요를 촉진하고 있습니다. 이는 혁신적인 치약 제형, 구강 청결제, 첨단 치과 기구 등 새로운 제품과 기술의 시장 도입으로 이어졌습니다.
예를 들어, 2022년 5월에는 유럽 치주학회(EFP)가 주최한 세계적인 인식 개선 캠페인인 '잇몸 건강의 날 2022'의 슬로건이 "잇몸을 소중히 여기세요(Treat your Gums)"였습니다. 이 행사는 치은염, 치주염, 임플란트 주위 점막염, 임플란트 주위염과 같은 잇몸 질환이 구강 건강과 전반적인 건강에 미치는 악영향에 대해 대중에게 알리는 것을 목표로 합니다. 이 캠페인은 잇몸 질환의 예방, 조기 발견, 그리고 필요한 경우 효과적인 치료를 촉구합니다.

또한, 치은염 유병률 증가, 치료 옵션의 발전, 주요 업체 및 기타 기업의 협력 및 투자 증가는 예측 기간 동안 시장 성장을 더욱 촉진할 것입니다.
시장 동향: 제약 요인
만성 치은염은 당뇨병, 뇌졸중, 류마티스 관절염, 관상동맥 질환과 같은 전신 질환과 관련이 있습니다. 가장 흔한 합병증은 치은염으로, 치아 손실로 이어집니다. 항치은염제는 구강 자극, 염증, 구강 건조, 이상한 맛을 유발할 수 있으며, 과다 사용 시 화학적 화상을 입을 수 있습니다.
세분화 분석
전 세계 치은염 치료 시장은 치료 유형, 판매 채널 및 지역별로 세분화됩니다.
치료 유형 부문에서 비수술적 치료는 시장 점유율의 약 41.2%를 차지했습니다.
치료 유형 부문에서 비수술적 치료 부문은 41.2%를 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 비수술적 의료 시술은 수술이 필요하지 않은 질병이나 부상과 같은 문제를 진단, 측정, 모니터링 또는 치료하는 데 사용됩니다. 비수술적 치료는 최소 침습적이고 비용 효율적이며 환자 중심적인 접근 방식을 제공하기 때문에 예측 기간 동안 이 분야의 성장을 견인할 것입니다.
예를 들어, 2022년 4월 텍사스 대학교 샌안토니오 건강과학센터(UT Health San Antonio)는 미국 국립보건원(NIH)으로부터 치주 질환(잇몸 질환)에 대한 항생제 사용 연구를 위해 4년간 240만 달러의 지원금을 받았습니다.
지역 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 구강 건강의 중요성에 대한 인식이 높아지고, 새로운 치약 제형, 첨단 치과 기기, 혁신적인 구강 관리 제품을 포함한 치은염 치료 제품의 기술 발전으로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 북미에서는 치과 보험이 널리 보급되어 있어 사람들이 치은염 치료 제품 및 서비스, 새로운 제형 출시 등에 더 쉽게 접근할 수 있습니다.
2022년 7월, Pharmascience Inc.의 자회사인 Pendopharm은 새로운 무알코올 치은염 구강 세정제인 PrPERICHLOR WITHOUT ALCOHOL을 출시하게 되어 기쁩니다. PrPERICHLOR WITHOUT ALCOHOL은 중등도에서 중증 치은염 치료를 위한 전문 프로그램의 일환으로, 그리고 치과 방문 사이에 발생하는 치은 출혈 및 염증 관리에 사용하도록 적응증이 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹으로 인해 치과 진료 시간이 단축되고 응급 시술을 제외하고는 치과가 문을 닫게 되었습니다. 이로 인해 사람들이 정기적인 치과 진료를 받는 데 어려움을 겪었습니다. 또한 COVID-19는 장기 부전, 전신 질환, 그리고 치주 질환을 포함한 구강 건강 악화를 유발합니다. 과도한 염증성 사이토카인으로 유발되는 사이토카인 폭풍은 조직 손상으로 이어집니다.

일반적인 위험 요인으로는 비만, 당뇨병, 심혈관 질환, 고령, 흡연 등이 있습니다. 코로나19 감염 증상으로는 궤양, 미란, 백적색 반점, 염증 후 색소 침착, 점상 출혈, 다형 홍반 유사 병변, 괴사성 치주 질환 등이 있으며, 잇몸이 흔히 침범되는 부위입니다.
경쟁 환경
치은염 치료 시장의 주요 글로벌 업체로는 Citron Pharma, Pfizer plc, Novartis AG, Wellona Pharma, Medtronic, Aspen Pharma, Harfins Instruments, AsaDental, Advil, Ora Pharma 등이 있습니다.
주요 동향
 2023년 5월, Bausch Health Companies Inc.와 구강 건강 관리 사업부인 OraPharma는 월드 시리즈 챔피언 알렉스 로드리게스와 협력하여 잇몸 질환의 유병률과 영향에 대한 전국적인 인식 개선 캠페인을 시작한다고 발표했습니다. 이 캠페인은 6월 한 달 동안 진행되는 구강 건강의 달에 맞춰 시작되었으며, 알렉스가 환자 홍보대사로 참여했습니다.
 2023년 1월, 애쉬랜드는 잇몸의 생물학적 균형을 유지하는 데 도움을 주는 자연적이고 안전하며 효과적인 바이오 활성 성분을 함유한 기능성 구강 관리 제품인 사프라길(Saffragyl)을 출시했습니다. 사프라길은 잇몸염에 취약한 잇몸을 예방하는 데 효과적이며, 구강 내 미생물 환경과 잇몸에 안전하고 매일 사용할 수 있습니다.
 2022년 10월, 버밍엄 대학교 연구진이 잇몸 질환 신속 진단법을 개발 중이라고 발표했습니다. 치과나 약국 등 현장에서 바로 사용할 수 있도록 설계된 이 검사법은 심장 또는 폐 질환, 제2형 당뇨병, 류마티스 관절염 등의 조기 진단에 도움이 될 것으로 기대됩니다.
보고서를 구매해야 하는 이유?

• 전 세계 치은염 치료 시장을 유형, 치료 유형, 판매 채널 및 지역별로 세분화하여 시각화하고 주요 상업 자산과 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.
• 모든 세그먼트를 포함한 치은염 치료 시장 수준의 다양한 데이터가 담긴 엑셀 자료를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

전 세계 치은염 치료 시장 보고서는 약 69개의 표, 70개의 그림, 185페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Gingivitis Treatment Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
Gingivitis is an inflammatory condition of the gingival tissue, most commonly caused by bacterial infection. Unlike periodontitis, there is no attachment loss and therefore no migration of the junctional epithelium. The condition is restricted to the soft-tissue area of the gingival epithelium and connective tissue. Among all the periodontal diseases, gingivitis is considered to be the commonest.
Gingivitis is caused by microbial plaque deposits located in or close to the gingival sulcus. The microorganisms more strongly associated with the etiology of gingivitis include species of Streptococcus, Fusobacterium, Actinomyces, Veillonella, and Treponema. Bacteroides, Capnocytophaga, and Eikenella are also potentially linked to the etiology of the disease.
Market Dynamics: Drivers and Restraints
Rise in awareness and improved management
In addition, increasing disposable incomes and growing awareness of the importance of oral health are driving demand for high-quality oral care products, including those used for gingivitis treatment. This has led to the introduction of new products and technologies in the market, including innovative toothpaste formulations, mouthwashes, and advanced dental instruments.
For instance, in May 2022, Treat your Gums was the slogan for Gum Health Day 2022, a worldwide awareness campaign organised by the European Federation of Periodontology (EFP). The event aims to inform the public of the detrimental effects of gum diseases – gingivitis, periodontitis, peri-implant mucositis, and peri-implantitis on both oral and overall health. The campaign calls for the prevention, early detection, and where necessary effective treatment of gum diseases.
Furthermore, a rise in the prevalence of gingivitis, a rise in advancements in treatment options, collaborations and investments by key players and others will further drive the market to grow during the forecast period.
Market Dynamics: Restraint
Chronic gingiva inflammation is linked to systemic conditions like diabetes, stroke, rheumatoid arthritis, and coronary artery disease. The most common complication is gingivitis, which leads to tooth loss. Anti-gingivitis agents can cause mouth irritation, inflammation, dry mouth, and unusual tastes, with overuse potentially causing chemical burns.
Segment Analysis
The global gingivitis treatment is segmented based on treatment type, sales channel and region.
The non-surgical treatment from the treatment type segment accounted for approximately 41.2% of the market share
The non-surgical segment from the treatment type segment accounted for 41.2% and it is expected to dominate during the forecast period. Non-surgical medical procedures are used to diagnose, measure, monitor or treat problems such as diseases or injuries that don't require surgery. Owing to the non-surgical treatment are minimally invasive, cost-effective, patient-centric approach will drive this segment during the forecast period.
For instance, in April 2022, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a four-year award of $2.4m from the US National Institutes of Health (NIH) to study the usage of antibiotics for periodontal disease, commonly called gum disease.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to a growing awareness of the importance of oral health in North America, significant technological advances in gingivitis treatment products, including new toothpaste formulations, advanced dental instruments, and innovative oral care products. Dental insurance is widely available in North America, which makes it easier for people to access gingivitis treatment products and services, novel formulation launches and others.
In July 2022, Pendopharm, a division of Pharmascience Inc., is pleased to introduce PrPERICHLOR WITHOUT ALCOHOL, a new alcohol-free formulation of its gingivitis mouthwash.PrPERICHLOR WITHOUT ALCOHOL is indicated for use as part of a professional program for the treatment of moderate to severe gingivitis, and for management of associated gingival bleeding and inflammation between dental visits.
COVID-19 Impact Analysis
The COVID-19 pandemic led to reduced opening hours and the closure of dental practices, except in the case of emergency procedures. This has limited people’s ability to access routine care. Also, COVID-19 causes organ failure, systemic diseases, and poor oral health, including periodontal disease. The cytokine storm, induced by excessive proinflammatory cytokines, leads to tissue damage.
Common risk factors include obesity, diabetes, cardiovascular disease, age, and smoking. Symptoms of COVID-19 infection include ulcers, erosions, white-red plaques, post-inflammatory pigmentation, petechia, erythema multiforme-like lesions, and necrotizing periodontal disease, with gingiva being a common site of involvement.
Competitive Landscape
The major global players in the gingivitis treatment market include Citron Pharma, Pfizer plc, Novartis AG, Wellona Pharma, Medtronic, Aspen Pharma, Harfins Instruments, AsaDental, Advil, Ora Pharma and among others.
Key Developments
 In May 2023, Bausch Health Companies Inc. and its oral health care business, OraPharma, stated its collaboration with World Series Champion, Alex Rodriguez, to launch a national awareness campaign about the prevalence and impact of gum disease. The campaign launch is timed to Oral Health Month recognized throughout June and features Alex as a patient ambassador.
 In January 2023, Ashland launched saffragyl, a biofunctional that transforms oral health into a daily beauty regimen by proposing a natural, safe, and effective bioactive to take care of the biology of the gingiva. It offers a preventive answer to gums prone to gingivitis and is microbiome-friendly, gum-friendly and can be used daily.
 In October 2022, it was stated that a rapid test for gum disease was being developed by researchers at the University of Birmingham. The probe, designed for use in point-of-care settings such as dental surgeries or pharmacies, is expected to aid in the early detection of heart or lung disease, type 2 diabetes, and rheumatoid arthritis.
Why Purchase the Report?
• To visualize the global gingivitis treatment market segmentation-based type, treatment type, sales channel and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of gingivitis treatment market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global gingivitis treatment market report would provide approximately 69 tables, 70 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Treatment Type
3.3. Snippet by Sales Channel
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Driver
4.1.1.1. Rise in the awareness and improved management
4.1.1.2. Advancements in treatment options
4.1.2. Restraints
4.1.2.1. Complications associated with the disease
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Plaque Induced Gingivitis*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Nutritional Gingivitis
7.4. Hormonal Gingivitis
7.5. Drug-Induced Gingivitis
8. By Treatment Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
8.1.2. Market Attractiveness Index, By Treatment Type
8.2. Non-Surgical *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Surgical
9. By Sales Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
9.1.2. Market Attractiveness Index, By Sales Channel
9.2. End User *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Distribution Channel
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Citron Pharma
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Pfizer plc
12.3. Novartis AG
12.4. Wellona Pharma
12.5. Medtronic
12.6. Aspen Pharma
12.7. Harfins Instruments
12.8. AsaDental
12.9. Advil
12.10. Ora Pharma
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Citron Pharma, 4. Key Developments, Pfizer plc, Novartis AG, Wellona Pharma, Medtronic, Aspen Pharma, Harfins Instruments, AsaDental, Advil, Ora Pharma

표 목록 (Tables)

List of Tables Table 1 Global Gingivitis Treatment Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Gingivitis Treatment Market Value, By Drug Class, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Gingivitis Treatment Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Gingivitis Treatment Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Gingivitis Treatment Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Gingivitis Treatment Market Value, By Type, 2022-2033 (US$ Billion)

Table 7 Global Gingivitis Treatment Market Value, By Drug Class, 2025, 2029 & 2033 (US$ Billion)

Table 8 Global Gingivitis Treatment Market Value, By Drug Class, 2022-2033 (US$ Billion)

Table 9 Global Gingivitis Treatment Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)

Table 10 Global Gingivitis Treatment Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 11 Global Gingivitis Treatment Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 12 Global Gingivitis Treatment Market Value, By Region, 2022-2033 (US$ Billion)

Table 13 North America Gingivitis Treatment Market Value, By Type, 2022-2033 (US$ Billion)

Table 14 North America Gingivitis Treatment Market Value, By Drug Class, 2022-2033 (US$ Billion)

Table 15 North America Gingivitis Treatment Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 16 North America Gingivitis Treatment Market Value, By Country, 2022-2033 (US$ Billion)

Table 17 Europe Gingivitis Treatment Market Value, By Type, 2022-2033 (US$ Billion)

Table 18 Europe Gingivitis Treatment Market Value, By Drug Class, 2022-2033 (US$ Billion)

Table 19 Europe Gingivitis Treatment Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 20 Europe Gingivitis Treatment Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Asia-Pacific Gingivitis Treatment Market Value, By Type, 2022-2033 (US$ Billion)

Table 22 Asia-Pacific Gingivitis Treatment Market Value, By Drug Class, 2022-2033 (US$ Billion)

Table 23 Asia-Pacific Gingivitis Treatment Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 24 Asia-Pacific Gingivitis Treatment Market Value, By Country, 2022-2033 (US$ Billion)

Table 25 South America Gingivitis Treatment Market Value, By Type, 2022-2033 (US$ Billion)

Table 26 South America Gingivitis Treatment Market Value, By Drug Class, 2022-2033 (US$ Billion)

Table 27 South America Gingivitis Treatment Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 28 South America Gingivitis Treatment Market Value, By Country, 2022-2033 (US$ Billion)

Table 29 Middle East and Africa Gingivitis Treatment Market Value, By Type, 2022-2033 (US$ Billion)

Table 30 Middle East and Africa Gingivitis Treatment Market Value, By Drug Class, 2022-2033 (US$ Billion)

Table 31 Middle East and Africa Gingivitis Treatment Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 32 Middle East and Africa Gingivitis Treatment Market Value, By Country, 2022-2033 (US$ Billion)

Table 33 GSK plc.: Overview

Table 34 GSK plc.: Product Portfolio

Table 35 GSK plc.: Key Developments

Table 36 AbbVie Inc.: Overview

Table 37 AbbVie Inc.: Product Portfolio

Table 38 AbbVie Inc.: Key Developments

Table 39 Abbott: Overview

Table 40 Abbott: Product Portfolio

Table 41 Abbott: Key Developments

Table 42 Dr. Reddy’s Laboratories Ltd.: Overview

Table 43 Dr. Reddy’s Laboratories Ltd.: Product Portfolio

Table 44 Dr. Reddy’s Laboratories Ltd.: Key Developments

Table 45 Pfizer Inc.: Overview

Table 46 Pfizer Inc.: Product Portfolio

Table 47 Pfizer Inc.: Key Developments

Table 48 Micro Labs USA, Inc.: Overview

Table 49 Micro Labs USA, Inc.: Product Portfolio

Table 50 Micro Labs USA, Inc.: Key Developments

Table 51 Zydus Group.: Overview

Table 52 Zydus Group.: Product Portfolio

Table 53 Zydus Group.: Key Developments

Table 54 Bausch Health Companies Inc.: Overview

Table 55 Bausch Health Companies Inc.: Product Portfolio

Table 56 Bausch Health Companies Inc.: Key Developments

Table 57 3M: Overview

Table 58 3M: Product Portfolio

Table 59 3M: Key Developments

Table 60 Kenvue Brands LLC: Overview

Table 61 Kenvue Brands LLC: Product Portfolio

Table 62 Kenvue Brands LLC: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Gingivitis Treatment Market Share, By Type, 2024 & 2033 (%)

Figure 3 Global Gingivitis Treatment Market Share, By Drug Class, 2024 & 2033 (%)

Figure 4 Global Gingivitis Treatment Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 5 Global Gingivitis Treatment Market Share, By Region, 2024 & 2033 (%)

Figure 6 Global Gingivitis Treatment Market Y-o-Y Growth, By Type, 2023-2033 (%)

Figure 7 Plaque Induced Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 8 Nutritional Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 9 Hormonal Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 10 Drug-induced Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 11 Global Gingivitis Treatment Market Y-o-Y Growth, By Drug Class, 2023-2033 (%)

Figure 12 Antiseptics Drug Class in Global Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 13 Antibiotics Drug Class in Global Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 14 NSAID's Drug Class in Global Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 15 Others Drug Class in Global Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 16 Global Gingivitis Treatment Market Y-o-Y Growth, By Distribution Channel, 2023-2033 (%)

Figure 17 Hospital Pharmacies Distribution Channel in Global Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 18 Retail Pharmacies Distribution Channel in Global Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 19 Aquaculture Farms Distribution Channel in Global Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 20 Global Gingivitis Treatment Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 21 North America Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 22 North America Gingivitis Treatment Market Share, By Type, 2024 & 2033 (%)

Figure 23 North America Gingivitis Treatment Market Share, By Drug Class, 2024 & 2033 (%)

Figure 24 North America Gingivitis Treatment Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 25 North America Gingivitis Treatment Market Share, By Country, 2024 & 2033 (%)

Figure 26 Europe Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 27 Europe Gingivitis Treatment Market Share, By Type, 2024 & 2033 (%)

Figure 28 Europe Gingivitis Treatment Market Share, By Drug Class, 2024 & 2033 (%)

Figure 29 Europe Gingivitis Treatment Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 30 Europe Gingivitis Treatment Market Share, By Country, 2024 & 2033 (%)

Figure 31 Asia-Pacific Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 32 Asia-Pacific Gingivitis Treatment Market Share, By Type, 2024 & 2033 (%)

Figure 33 Asia-Pacific Gingivitis Treatment Market Share, By Drug Class, 2024 & 2033 (%)

Figure 34 Asia-Pacific Gingivitis Treatment Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 35 Asia-Pacific Gingivitis Treatment Market Share, By Country, 2024 & 2033 (%)

Figure 36 South America Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 37 South America Gingivitis Treatment Market Share, By Type, 2024 & 2033 (%)

Figure 38 South America Gingivitis Treatment Market Share, By Drug Class, 2024 & 2033 (%)

Figure 39 South America Gingivitis Treatment Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 40 South America Gingivitis Treatment Market Share, By Country, 2024 & 2033 (%)

Figure 41 Middle East and Africa Gingivitis Treatment Market Value, 2022-2033 (US$ Billion)

Figure 42 Middle East and Africa Gingivitis Treatment Market Share, By Type, 2024 & 2033 (%)

Figure 43 Middle East and Africa Gingivitis Treatment Market Share, By Drug Class, 2024 & 2033 (%)

Figure 44 Middle East and Africa Gingivitis Treatment Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 45 GSK plc.: Financials

Figure 46 AbbVie Inc.: Financials

Figure 47 Abbott.: Financials

Figure 48 Dr.Reddy’s Laboratories Ltd.: Financials

Figure 49 Pfizer Inc.: Financials

Figure 50 Micro Labs USA, Inc.: Financials

Figure 51 Zydus Group.: Financials

Figure 52 Bausch Health Companies Inc.: Financials

Figure 53 3M: Financials

Figure 54 Kenvue Brands LLC: Financials

세계 치은염 치료 시장 – 2023-2030

Global Gingivitis Treatment Market -2023-2030